Skip to main content

Molecular updating of β-thalassemia mutations in the upper Egyptian population.

Research Authors
Essam H. Jiffri, Neda Bogari, Khaled H. Zidan, Salwa Teama, and Nasser A. Elhawary
Research Date
Research Department
Research Publisher
Hemoglobin
Research Rank
ORIGINAL ARTICLE
Research Vol
34(6)
Research Website
DOI: 10.3109/03630269.2010.526440
Research Year
2010
Research_Pages
538–547
Research Abstract

We have updated the dataset of the molecular spectrum of the β-thalassemia (β-thal) in Upper
Egypt. Buccal swabs were analyzed from 94 unrelated patients with β-thal major (β-TM) using
reverse dot-blot and multiplex amplification refractory mutation system-polymerase chain reaction
(ARMS-PCR). The most frequent mutation was IVS-I-110 (G>A) (57%). The IVS-I-110, IVS-I-6
(T>C) and IVS-I-1 (G>A) mutations accounted for 87% of the β-thal anomalies. The codon 39
(C>T) and frameshift codon (FSC) 6 (–A) (GAG>–GG) mutations were only detected in Al-Minya
and Qina, respectively. We did not observe the IVS-II-745 (C>G) or –101 (C>T) mutations. Fortythree
percent of Upper Egyptians were homozygotes. Our efforts were an important step to complete
the mutation map of β-thal in Egypt restricted to Cairo and the Nile Delta regions. This study will
help to develop preventative programs for Upper Egyptians. It addressed the genetic drift of the β-thal
gene mutations in Africa, Asia, and Europe.